about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

Pfiz­er on­col­o­gy head Liz Bar­rett jumps ship to No­var­tis as Bruno St­rig­i­ni steps aside

8 years ago
People

Glob­al Blood Ther­a­peu­tic­s' sick­le cell dis­ease drug gets break­through ther­a­py sta­tus; Boehringer In­gel­heim will ...

8 years ago
News Briefing

Boast­ing a late-stage Botox me-too, Evo­lus files for $75M IPO

8 years ago
Financing

Shire cre­ates sep­a­rate neu­ro­sciences di­vi­sion for fu­ture in­vest­ments; Agenus gains $28M in roy­al­ty deal

8 years ago
News Briefing

Sanuj Ravin­dran to lead Pelle­Pharm as CEO; Paul Hast­ings leaves On­coMed; Mod­er­na taps John Mendlein as pres­i­dent

8 years ago
Peer Review

Lund­beck part­ners with Van­der­bilt on new schiz­o­phre­nia drug; Pere­grine of­fi­cial­ly re­named Avid BioSer­vices in pur­suit ...

8 years ago
News Briefing

INC Re­search and in­Ven­tiv Health come un­der Sy­neos Health brand in clos­ing chap­ter of CRO merg­er

8 years ago
Deals
Outsourcing

Cel­gene and blue­bird make a 'break­through' on BC­MA-tar­get­ing CAR-T; An­oth­er can­cer drug biotech gar­ners $39M start­up ...

8 years ago
News Briefing

Star drugs like BM­S' Op­di­vo, As­traZeneca's Lyn­parza will get speedy OKs in Chi­na this year, new re­port pre­dicts

8 years ago
China
Pharma

No­var­tis' Tafin­lar/Mekin­ist com­bo for melanoma gets pri­or­i­ty re­view des­ig­na­tion; Fo­s­un Phar­ma backs joint ven­ture's ...

8 years ago
News Briefing

Syn­er­gy CEO pass­es torch to CCO Troy Hamil­ton; Pres­i­dent Steven Kaf­ka re­signs from Foun­da­tion; Ab­b­Vie vet John ...

8 years ago
Peer Review

Tra­con inks deal with Am­brx to de­vel­op can­cer drug in Chi­na; Roche wins con­sec­u­tive ap­provals in EU and US

8 years ago
News Briefing

Andy Boy­er joins Te­va ex­o­dus; Achao­gen shuf­fles ex­ec­u­tive line­up

8 years ago
Peer Review

Cel­gene forges can­cer pact with CRT; FDA OKs Pfiz­er's Xel­janz as treat­ment for pso­ri­at­ic arthri­tis

8 years ago
News Briefing

Grail taps Genen­tech vet Jen­nifer Cook as CEO, build­ing ex­pec­ta­tions for 2018

8 years ago
People
Peer Review

Medi­gene, RXi strike re­search deal to im­prove TCRs; Bris­tol-My­ers pays PsiOxus $15M mile­stone for tri­al-ready ...

8 years ago
News Briefing

Hookipa rais­es $60M to fund im­munother­a­py R&D; Roche bags Io­n­is op­tion for $45M; Re­gen­eron fights back against ...

8 years ago
News Briefing

Cyn­thia Collins ex­its Hu­man Longevi­ty; Sec­tion 32 wel­comes Michael Pelli­ni; Sil­ver­back beefs up its C-suite

8 years ago
Peer Review

Lau­ra Shawver hits the ground run­ning, scout­ing new in­vestors for tiny Syn­thorx

8 years ago
Peer Review

Te­va boots its R&D chief; Iron­wood grows the C-suite and In­ter­cept taps new EVP of re­search

8 years ago
Peer Review

Vir chief Scan­gos picks Her­bert ‘Skip’ Vir­gin to run R&D; Arde­lyx forges $160M deal with Ky­owa Hakko Kirin

8 years ago
News Briefing

In­trex­on taps new COO, CBO in ex­ec­u­tive reshuf­fle; De­nali tar­gets up to $182M in IPO

8 years ago
News Briefing

Jeff Capel­lo joins Bio­gen as CFO; Tesaro en­ters $500M loan agree­ment; Palatin li­cens­es fe­male li­bido drug to Ko­re­a's ...

8 years ago
News Briefing

Pfiz­er reshuf­fles top ranks with Al­bert Bourla as COO; In­tra-cel­lu­lar nabs No­var­tis vet An­drew Satlin as CMO

8 years ago
Peer Review
First page Previous page 122123124125126 Next page Last page
A service from the Financial Times